Abstract

Alzheimer’s disease (AD) is the most common cause of senile dementia worldwide, characterized by both cognitive and behavioral deficits. Amyloid beta peptide (Aβ) oligomers (AβO) have been found to be responsible for several pathological mechanisms during the development of AD, including altered cellular homeostasis and synaptic function, inevitably leading to cell death. Such AβO deleterious effects provide a way for identifying new molecules with potential anti-AD properties. Available treatments minimally improve AD symptoms and do not extensively target intracellular pathways affected by AβO. Naturally-derived compounds have been proposed as potential modifiers of Aβ-induced neurodysfunction and cytotoxicity based on their availability and chemical diversity. Thus, the aim of this study was to evaluate boldine, an alkaloid derived from the bark and leaves of the Chilean tree Peumus boldus, and its capacity to block some dysfunctional processes caused by AβO. We examined the protective effect of boldine (1–10 μM) in primary hippocampal neurons and HT22 hippocampal-derived cell line treated with AβO (24–48 h). We found that boldine interacts with Aβ in silico affecting its aggregation and protecting hippocampal neurons from synaptic failure induced by AβO. Boldine also normalized changes in intracellular Ca2+ levels associated to mitochondria or endoplasmic reticulum in HT22 cells treated with AβO. In addition, boldine completely rescued the decrease in mitochondrial membrane potential (ΔΨm) and the increase in mitochondrial reactive oxygen species, and attenuated AβO-induced decrease in mitochondrial respiration in HT22 hippocampal cells. We conclude that boldine provides neuroprotection in AD models by both direct interactions with Aβ and by preventing oxidative stress and mitochondrial dysfunction. Additional studies are required to evaluate the effect of boldine on cognitive and behavioral deficits induced by Aβ in vivo.

Highlights

  • Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder characterized by cognitive and behavioral deficits (Terry et al, 1991) that is expected to reach 82 million cases in 2030 (Weidner and Barbarino, 2019)

  • The present study shows that boldine can interact with Aβ in silico and inhibit its aggregation at low micromolar concentrations

  • Boldine was able to attenuate the synaptic failure induced by Aβ oligomers (AβO), along with calcium and mitochondrial dyshomeostasis, suggesting that it could act as a natural antiAD compound

Read more

Summary

Introduction

Alzheimer’s Disease (AD) is the most prevalent neurodegenerative disorder characterized by cognitive and behavioral deficits (Terry et al, 1991) that is expected to reach 82 million cases in 2030 (Weidner and Barbarino, 2019). Less than 1% of cases are associated with familial forms due to mutations in the presenilin 1 or presenilin 2 genes involved in the processing of the amyloid precursor protein (APP) (Masters et al, 2015). AD pathology shows progressive neuronal damage and atrophy in vulnerable brain regions and circuits involved in memory, in the hippocampus and cerebral cortex. These events appear to be preceded by synaptic and neuronal dysfunction. AD is characterized by the presence of extracellular plaques mainly composed of misfolded fibrillar amyloid beta peptide (Aβ) derived from the amyloidogenic processing of the APP by β- and γ-secretases, and intraneuronal neurofibrillary tangles consisting of aggregates of hyperphosphorylated tau protein (Ferreira et al, 2012b; Cline et al, 2018, for review). We have confirmed these original findings on the synaptoxicity of AβO and further characterized the toxic components of these Aβ assemblies by oligomerization time curves, characterization of dimer and tretramers and by atomic force microscopy that reported nanometric structures (González-Sanmiguel et al, 2020)

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call